Sie sind auf Seite 1von 25


Agarwal, V., Metlitskaya, A., Severinov, K., Nair, SK. (2011). Structural basis for microcin C7 inactivation by the MccE acetyltransferase.J. Biol. Chem. 286(24):21295-21303. Anne-Marie , P., Nathalie, Z., David ,V., Franois, D., Alain, V., and Gilles, C. (2002).Microcin E492 Is an Unmodified Peptide Related in Structure to Colicin V. Antimicrob. Agents. Chemother. 46(1): 229230. Asensio, C., Prez-Daz, JC. (1976). A new family of low molecular weight antibiotics from enterobacteria. Biochemical and Biophysical Research Communications. 69.( 1): 7-14. Augusto, B., Paula, A., Vincent, B., de Arcuri,F., Ricardo, N., Faras, and Roberto D. (2007).Microcin J25 Has Dual and Independent Mechanisms of Action in Escherichia coli : RNA Polymerase Inhibition and Increased Superoxide Production.J. Bacteriol. 189(11): 4180-4186. Azpiroz, MF., Bascuas, T., Lavin a, M. (2011). Microcin H47 System: An Escherichia coli Small Genomic Island with Novel Features. Plos one. 6(10): 1-9. Azpiroz, MF., Poey, ME., Lavia, M. (2009). Microcins and urovirulence in Escherichia coli . Microb. Pathog. 47: 274280. Bastos, M.C.F., Coutinho, B.G., Coelho, with M.L.V.(2010).A Clinical




Applications. Pharmaceuticals. 3(4):1139-1161.



Benson, H.J. (2001). Microbiological application, laboratory manual in general microbiology. 8th. ed. W.b. Mcgraw Hill.pp;112130. Berg, Jeremy, M.( 2007). Biochemistry. Sixth Ed. New York: W.H. Freeman. 78.pp;68-69. Berg, JM., Tymoczko, JL, Stryer, L.(2002).The Purification of Proteins I.s an Essential First Step in Understanding Their Function.Biochemistry. 5th edition. New York. Section 4.1. Bister, B., Bischoff, D., Nicholson, GJ., Valdebenito, M., Schneider, K., Winkelmann, G., Hantke, K., Sssmuth, RD.(2004).The structure of salmochelins: C-glucosylated enterobactins of Salmonella enterica. Biometals. 17(4):471-481. Blahna, M. T., C. A. Zalewski, J. Reuer, G. Kahlmeter, Foxman, B., Marrs, C. F. (2006) The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. J. Antimicrob. Chemother. 57: 666-672. Brssow, H., Canchaya, C., Hardt, WD. (2004). Phages and the evolution of bacterial pathogens: from genomic

rearrangements to lysogenic conversion. Microbiol. Mol. Biol. Rev. 68 (3): 560602. Budic, M., Rijavec, M., Petkovek, coli ., gur-Bertok, D.

(2011) Escherichia



Efficacy and Prevalence among Isolates from Patients with Bacteraemia. Plos one. 6(12): 1-11.



Cao, Z., Klebba, PE. (2002). Mechanisms of colicin binding and transport through outer membrane porins. Biochimie 84(56): 399412. Cascales, E., Buchanan, SK., Duch, D., Kleanthous, C., Lloubs, R., Postle, K., Riley, M., Slatin, S., Cavard, D.(2007).Colicin biology. Microbiol. Mol. Biol. Rev. 71(1):158-229. Chiuchiolo, M., Delgado, M.A., Faras, R.N., and Salomn, R.A. (2001) Growth-phase-dependent expression of the cyclopeptide antibiotic microcin J25. J. Bacteriol .183:1755 1764. Christopher, T., Lohans, John, C., Vederas. (2011). Development of Class IIa Bacteriocins as Therapeutic Agents. International Journal of Microbiology :13.pp;1-13 Claudio, H., Maria, R., Bono, L., Felipe, B., and Rosalba, L.(2002). Microcin E492, a channel-forming bacteriocin from

Klebsiella pneumoniae, induces apoptosis in some human cell lines. PNAS .99 (5):2696-2701. Cockerill, F., Wikler , M., Bush, K., Dudley, M., Eliopoules, G., Hardy, D., Hecht, D. , Hindler , J., Patel , J. , Powell , M., Thomson , R. , Turnidge , J., Weinstein , M. , Zimmer,B.Ferraro,M.and standards for Swenson,J.(2010).Performance susceptibility testing .


Twentienth information supplement. 30(1):30-40. Collee, J.G., Miles, R.S., Wan, B. (1996). Tests for the identification of bacteria. In: Mackie and McCartney



practical medical microbiology, Eds., Collee J.G., Fraser A.G., Marmion B.P., Simmons A. Edinburgh: Churchill Livingstone, pp: 131-150. Collin, F., Thompson, RE., Jolliffe, KA., Payne, RJ., Maxwell, A. (2013) Fragments of the Bacterial Toxin Microcin B17 as Gyrase Poisons. Plos one 8(4): 1-7. Corsini, G., Karahanian, D., Saavedra, E., Tello, M., Fernandez, A.(2010). K., Rivero, and

JM., Ferrer,


characterization of the antimicrobial peptide microcin N. FEMS Microbiol Lett. ;312(2):119-125. Cotter, PD., Hill, C., Ross, RP. (2006). What's in a name? Class distinction for bacteriocins. Nature Reviews

Microbiology .4 (2):194-208. Cotter, PD., Hill, C., Ross, RP. (2005).Bacteriocins: developing innate immunity for food.Nature Reviews Microbiology .3(10):777788. Cramer, W.A., Zakharov, SD., Antonenko, YN., Kotova, EA. (2004). On the role of lipid in colicin pore formation. Biochim. Biophys. Acta.1666(1-2):239-249. Cress, BF., Linhardt, RJ., Koffas, MAG. (2013).Draft Genome Sequence of Escherichia coli Strain Nissle 1917 (Serovar O6:K5:H1).Genome Announc. 1(2):1-13. Darnton, N., Turner, L., Rojevsky, S., Berg, HC. (2007). On torque and tumbling in swimming Escherichia coli . J. Bacteriol. 189 (5): 17561764.



David, M., Gordon, and Claire, L., OBrien.(2006). Bacteriocin diversity and the frequency of multiple bacteriocin production in Escherichia coli . Microbiology . 152: 3239 3244. David, ., Lenka, M., Jan, ., Martin,V., Alena in .,ZuzanaV.,VladanaW.(2010).Bacteriocin synthesis

uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor.BMC. Microbiology.10:270288. Destoumieux-Garzn, D., Thomas, X., Santamaria, M., Goulard, C., Barthlmy, M., Boscher, B., Bessin, Y., Molle, G., Pons, AM., Letellier, L., Peduzzi, J., Rebuffat, S.(2003).Microcin E492 antibacterial activity: evidence for a TonB-dependent inner membrane permeabilization on Escherichia coli .Mol. Microbiol. 49(4):1031-1041. Djamel, D,.Sylvie, R. (2011). Prokaryotic Antimicrobial Peptides.1 st ed. Springer New York Dordrecht Heidelberg London.pp;5572 . Djamel, D., Gunnar, F., Yann, H., Lynn, M., Herv, P. (2006).The Continuing Story of Class IIa Bacteriocins. Microbiol .Mol.Biol. Rev. 2006 June; 70(2): 564582. Duquesne, S., Destoumieux-Garzon, D., Peduzzi, J., Rebuffat, S. (2007a) Microcins gene-encoded antibacterial peptides from enterobacteria. Nat .Prod .Rep .24: 708-734.



Duquesne, S., Petit, V., Peduzzi, J., Rebuffat, S.(2007b).Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria. J. Mol. Microbiol. Biotechnol. 13(4):200-209. Eckburg, P., Bik, E., Bernstein, C., Purdom, E., Dethlefsen, L., Sargent, M., Gill, of S., the Nelson, human K., Relman, D.

(2005). Diversity



flora. Science .308 (5728):16351638. Eliana, R., and Magela, L. (2003).The Proton Channel Is the Minimal Structure of ATP Synthase Necessary and Sufficient for Microcin H47 Antibiotic Action.Antimicrob Agents Chemother. 47(1): 181187. Eliana, R., Carina, G., Magela, L.(1999).The Structural Gene for Microcin H47 Encodes a Peptide Precursor with Antibiotic Activity.Antimicrob Agents Chemother.43(9): 21762182. Elizabeth, M., Malin, G., and Go Ran Kronvall. (2004). Integrons and multidrug resistance among Escherichia coli causing community-acquired urinary tract infection in southern India. APMIS. 112: 159164. Fatemeh, F., Hamideh, B., Arezou, M., Gita, E., Mostafa, S., Sedigheh, R., Tabatabaei, and Mohammad, AM. (2008). Antimicrobial resistance pattern in urinary tract infections in children on continuous ambulatory peritoneal dialysis. Iran. Jour. of Clini. Infecti. Dis., 3: 155-159. Feng, P., Weagant, S., Grant, M. the (2002). Enumeration Coliform Bacteria

of Escherichia

coli and



. Bacteriological Analytical Manual (8th ed.). FDA/Center for Food Safety & Applied Nutrition. Retrieved 2007-01-25. Fleckenstein, J. M., Hardwidge, P., Munson, G., Rasko, D., Sommerfelt, H., Steinsland, H. (2010). Molecular

mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect. 12:89-98. Fomenko, D., Veselovskii, A., and Khmel, I. (2001) .Regulation of microcin C51 operon expression: the role of global regulators of transcription. Res. Microbiol. 152: 469479. Forbes, A., Daniel, S., and Alice, S. (2007). Bailey and Scott's diagnostic microbiology. 12th. ed.Mosby Elsevier company, USA.pp;450-472. Fotadar, U., Zaveloff, P., Terracio, L. (2005). Growth of Escherichia coli at elevated temperatures. J. Basic. Microbiol. 45 (5): 403404. Gbor, N., Ulrich, D., Gyrgy, S., A., Salam, K., Jrg, H., Levente, E. (2002).Loss of Regulatory Protein RfaH Attenuates Virulence of Uropathogenic Escherichia .Immun.70 (8): 44064413. Gabriela, M., Mario, T., Macarena, M., Octavio, M., Rosalba, L.The Production In Vivo of Microcin E492 with Antibacterial Activity Depends on Salmochelin and EntF.(2008).J. Bacteriol. 190 (5): 5464-5471. coli . Infect



Galle, V., Delphine, D., Jean, P. (2011). Prokaryotic Antimicrobial Peptides. 1st ed. Springer New York Dordrecht Heidelberg London .pp;309-332. Galle, V., Jean, P., Sverine, Z., Xavier, T., Sylvie, R., Delphine D.G.(2007).Modification for Microcin E492

Posttranslational Biosynthesis: Enterobactin Is a Precursor Insight into Siderophore-Carrying Peptide. Antimicrob. Agents Chemother. 51(10):3546-3553. Gillor, O., Nigro, LM., Riley, MA.( 2005). Genetically Engineered Bacteriocins and Their Potential as the Next Generation of antimicrobials. Current Pharmaceutical Design. 11: 10671075 Gordon, D., Jeziorowski, A.( 2007). Evolution of Microcin V and Colicin Ia Plasmids in Escherichia coli . Journal of Bacteriology. 189: 7045- 2507 Gordon, K., and Jones, R. (2003). Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program . Diagn. Microbiol. Infect. Dis .45: 295-301. Goswami, R., C., Bal., S., Tejaswi., G., Punjabi and Kochupillai, N. (2001). Prevalence of urinary tract infection and renal scars in patients with diabetes mellitus. Diabetes. Res. Clin. Pract. 53(3): 181-186.



Gratia, JP. (2000). Andr Gratia: a forerunner in microbial and viral genetics. The Genetics Society of America. 156 (2): 471476. Guarner, F., Schaafsma, G. (1998). Probiotics. Int J Food Microbiol .39: 237238. Gupta, K., Hooton, T., Naber, K., Wullt, B., Colgan, R., L., G., Miller, G., J. Moran, L., E., Nicolle, R., Raz, J., Schaeffer & Soper, D.(2011). International clinical practice guidelines for the treatment of acute uncomplicated cystitis and

pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 52: 103-120. Gupta, S.(1975).Killing and Lysis of Escherichia coli in the Presence of Chloramphenicol: Relation to Cellular Magnesium.Antimicrob Agents Chemother. 7(6): 748753. Haghi-Ashteiani, M., Sadeghifard, N., Abedini M., Soroush, S., Taheri-Kalani, M.(2007). Etiology and antibacterial resistance of bacterial urinary tract infections in Childrens Medical Center, Tehran, Iran. Acta Med Iran.45(2):153-157. Hantke, K., G. Nicholson, W., Rabsch,G., Winkelmann.

(2003).Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc Natl Acad Sci U S A. 100(7): 36773682.



Harrington, S.,M., E.,G., Dudley, J.,P., Nataro. ( 2006).Pathogenesis of enteroaggregative Escherichia coli infection. FEMS. Microbiol. Lett. 254(1): 12-18. Heaton, JC., Jones, K. (2008). Microbial contamination of fruit and vegetables and the behaviour of enteropathogens in the phyllosphere . J. Appl. Microbiol. 104 (3): 613626. Heng, C.,K., N., Wescombe, P., A., Burton, J., P., Jack, R., W., & Tagg, J. R. (2007). The diversity of bacteriocins in Grampositive bacteria. In: Bacteriocins: Ecology and Evolution. 1st ed., Riley, M. A. & Chavan, M. A., Eds. Springer, Hildberg, p. 45-83. Hidron, A. I., Edwards, J., Patel, T., Horan, D.,Sievert, Pollock, D., & Fridkin, S. K. (2008) NHSN annual update: antimicrobialresistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control. Hosp Epidemiol. 29: 996-1011. Hirak, Jyoti, C., Protip, B., Sayak, G., Sasti, G., Paushali, R., Sohini, G., and Abhijit, D.(2011). Lantibase- A Lantibiotics Resource. Journal of Pharmaceutical and Biomedical Sciences.4(11):2230-7885. Hooton, T., Bradley, M., Cardenas, D., Colgan, R., Geerlings, S., Rice, J., Saint, S., Schaeffer, A., Tambayh, P., Tenke, P., & Nicolle, L. (2010) Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009



International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infec.t Dis .50: 625-663. Ingolf, F., Sung-Sik Yoon, N,.Dzung, B., Diep.(2007). Ribosomally Synthesiszed Antimicrobial Peptides (Bacteriocins) in Lactic Acid Bacteria. Food Sci. Biotechnol. 16( 5) : 675 690. Isa, GOkce, Jeremy, H., Lakey.(2003).Production of an E. coli Toxin Protein; Colicin A in E. coli Using an Inducible System.Turk J Chem.27 . pp:323- 331. James, B., Kaper, James, Nataro, P., Harry, coli . L.,




Reviews Microbiology. 8. pp;26-38. Jennifer, C., Thomas, J., Montville, Ingolf, F., Nes, Michael, L., Chikindas. (2001). Bacteriocins: safe and natural antimicrobials for food preservation. International Journal of Food Microbiology. 71:120. Joly-Guillou, M-L., Marie, K., Jean-Didier, C., Monique, C., Luc, D., Jeanne, M., Muller-Serieys, C., and Roussel-Delvallez, M.(2010). Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre studya. BMC Infectious Diseases.pp; 10-72 Jon, N-M, Camilla, O., Per, R., Helen, S.,Per Eugen

K.(2010).Structure and Mode-of-Action of the Two-Peptide (Class-IIb) Bacteriocins.Probiotics Antimicrob Proteins. 2(1): 5260.



Jonathan, G., Heddle, Stephen, J., Blance, Deborah, B., Zamble, F., Hollfelder, Deborah, A., Miller, Lois, M., Wentzell Christopher T. Walsh and Anthony Maxwell.(2001).The Antibiotic Microcin B17 is a DNA Gyrase Poison: Characterisation of the Mode of Inhibition. J. Mol. Biol. 307:1223-1234. Jose, L., Martinez, Jose, C., Perez-Diaz.(1986).Isolation,

characterization, and mode of action on E.coli strains of microsin D93. Antimicrobial Agent and chemotherapy. 29(3):456-460. Kang, C., Postle, K., Chen, G., Park, H., Youn, B., Hilsenbeck, JL. (2004). Crystal structure of the cytotoxic bacterial protein colicin B at 2.5 A resolution. Mol. Microbiol. 51 (3). pp;1-20 Karen, E., Roger, B.(2002). Media Preparation and Bacteriological Tools. Current Protocols in Molecular Biology 1.1.1-1.1.7. Kazakov, T., G. H. Vondenhoff, M. K. A. Datsenko, Novikova, M., A. Metlitskaya, B. L. Wanner, and K. Severinov. (2008). Escherichia coli peptidase A, B, or N can process translation inhibitor microcin C. J. Bacteriol. 190:2607 2610. Kebira, A.N., P. Ochola and S.A. Khamadi. (2009). Isolation and antimicrobial susceptibility testing of Escherichia coli causing urinary tract infections. J. Applied. Biosciences., 22: 1320 1325.



Kelleher, N.L., Hendrickson, C.L.,

Walsh, C.T. (1999)

Posttranslational heterocyclization of cysteine and serine residues in the antibiotic microcin B17: distributivity and directionality. Biochemistry 38: 1562315630. Kirkup, BC. (2006). Bacteriocins as oral and gastrointestinal antibiotics: theoretical considerations, applied research, and practical applications. Curr. Med. Chem. 13 (27): 3335 3350. Kirkup, BC., Riley, MA. (2004) Antibiotic-mediated antagonism leads to a bacterial game of rock-paper-scissors in vivo. Nature 428: 412414. Kleiger, G., Grothe, R., Mallick, P., Eisenberg, D.(2002).GXXXG and AXXXA: common alpha-helical interaction motifs in proteins, particularly in extremophiles .Biochemistry.

41(19):5990-5997. Klevens, M., Edwards, J., & Gaynes, R. (2008) The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States. Clin. Infect. Dis. 47: 927-930. Komprda, T., Smela, D., Pechova, P., Kalhotka, L., Stencl, J., Klejdus, B.(2004). Effect of starter culture, spice mix and storage time and temperature on biogenic amine content of dry fermented sausages. Meat Sci.67 (4):607616. Konstantin, S., Ekaterina, S., Alexey, K., Teymur Kazakov, and Mikhail. S., Gelfand.(2007).Low-molecular-weight posttranslationally modified microcins.Molecular Microbiology . 65(6): 13801394.



Lan, R., Alles, M., Donohoe K., Martinez M., Reeves P.( 2004). Molecular evolutionary relationships of enteroinvasive Escherichia coli and Shigella spp. Infect. Immun. 72 (9): 50805088. Lee, H., Kim, H.(2011).Lantibiotics, class I bacteriocins from the genus Bacillus.J Microbiol Biotechnol. 21(3):229-235. Li, M., Milne, C., Madison, L., Kolter, R., and Walsh, C. (1996) From peptide precursors to oxazole and thiazole-containing peptide antibiotics: microcin B17 synthase. Science 274: 11881193. Lisa, C., Crossman, Roy, R., Chaudhuri, Scott, A., Beatson, Timothy, J., Wells, Mickael, D., Adam, F. ,Cunningham, Nicola, K., Petty, Vivienne, M., Carl, B., Jon, L., Hobman, Stephen, J. ,Savarino, Susan, M., Turner, Mark, J., Pallen, Charles, W., Penn, Julian, Parkhill, A., Keith, T., Timothy, J., Johnson, Nicholas, R., Thomson, S., Smith, G., and Ian, R., Henderson .(2010).A Commensal Gone Bad: Complete Genome Sequence of the Prototypical Enterotoxigenic Escherichia coli Strain H10407. J. Bacteriol. 192 (21): 5822-5831. Lodish , H. , Berk , A., and Matsudaira , P. (2004) . Molecular Cell Biology 5th ED . W. H. Freeman : New York , Mara, E,. Poey, Mara, F., Azpiroz, Magela, L.(2006).Comparative Analysis of Chromosome-Encoded Microcins. Antimicrobial Agents and Chemotherapy.50 (4):14111418.



Mara, F., Azpiroz, and Magelam, L. (2007).Modular Structure of Microcin H47 and Colicin V.Antimicrobial Agents and Chemotherapy, 51(7): 24122419. Maria, C., Collado, M., Cernada, Christine, B.,Mximo V., and Gaspar, P-M.(2012).Microbial ecology and host-microbiota interactions during early life stages.Gut Microbes. 352365. Mara, J., Chiuchiolo, M nica, A., Delgado, Ricardo, N., Faras, and Ral, A., Salomn.(2001).Growth-Phase-Dependent 3(4):

Expression of the Cyclopeptide Antibiotic Microcin J25.J. Bacteriol. 183( 5): 1755-1764. Mary, K., York, E., Jill, E., Clarridge, Richard, B., Thomson, M., P., Weinstein.(2000). Multilaboratory Validation of Rapid Spot Tests for Identification of Escherichia coli . J. Clin. Microbiol..38 ( 9 ):3394-3398. Mathavan, I., Beis, K.(2012).The role of bacterial membrane proteins in the nternalization of microcin MccJ25 and

MccB17.Biochem .Soc. Trans. 40(6):1539-43. Mazumdar, K., Dutta, NK., Dastidar, SG., Motohashi, N., Shirataki, Y.(2006).Diclofenac in the management of E. coli urinary tract infections. In Vivo. .20(5):613-619. McFaddin, J.F. (2000). Biochemical tests for identification of medical bacteria. 1st Ed. The Williams and Wilkins. Baltimore, USA.pp;587-593.



Metlitskaya, A., Kazakov, T., Kommer, A., Pavlova, O., PraetoriusIbba, M., Ibba, M. (2006) .Aspartyl-tRNA synthetase is the target of peptide nucleotide antibiotic Microcin C. J .Biol .Chem. 281: 1803318042. Miniatis , T. , Frtsch , E., Sambrook , J. (1982) . Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y.pp;325-337. Morten, Kjos, Ingolf, F., Nes, and Dzung, B., Diep.(2009).Class II one-peptide bacteriocins target a phylogenetically defined subgroup of mannose phosphotransferase systems on sensitive cells.Microbiology. 155(9); 29492961. Murray, R., Baron, J., Jorgensen, H., Pfaller, A., Yolen, H. (2003). Manual of clinical microbiology. 8th. ed., American Society for Clinical Microbiology, Washington, DC.,Vol (1).pp;390425. Netz, A., Sahl , Nascimento , Oliveira , Soares , Bastos, M. (2001). Molecular characterisation of aureocin A70, a multiplepeptide bacteriocin isolated from Staphylococcus aureus. J. Mol. Biol 311: 939949. Nguyen, Y., Vanessa, S.(2012).Enterohemorrhagic E. coli (EHEC) pathogenesis. Front Cell Infect Microbiol.2: 90. Nissen-Meyer, J., Rogne P, Oppegrd C, Haugen HS, Kristiansen PE.(2009). Structure-function peptide relationships (class bacteria. II) of non-

lanthionine-containing produced by Biotechnol.10(1):1937.

bacteriocins Pharm.





Novikova, M., A. Metlitskaya, A., K. Datsenko, T. Kazakov, A. Kazakov, B. Wanner, and K. Severinov. (2007). The Escherichia coli Yej ABC transporter is required for the uptake of translation inhibitor microcin C. J. Bacteriol. 189:83618365. Olivier, T., David, S., Bertrand, P., Erick, D.(2010).The population genetics of commensal Escherichia coli .Nature Reviews microbiology. 8.207-217. Oman, J., Boettcher, M., Wang, H., Okalibe, N., & Van der, Donk, A. (2011). Sublancin is not a Lantibiotic but an s-Linked Glycopeptide. Nat. Chem. Biol. 7(2):78-80. Patricia, Escobar-Pramo, Karine, G., Arnaud, M., Luc Rode, E., Salgado, C., Amorin, Stphanie, G., Bertrand, P., Mohamed, R., Antoine, A., Erick, D., Raymond, R.(2004).Large-Scale Population Structure of Human Commensal Escherichia coli Isolates. Appl. Environ. Microbiol. 70(9): 56985700. Patzer, S., Baquero, M., Bravo, D. (2003) .The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology .149: 2557-2570. Paul, M., Van der, Donk, A. (2005).Chemical and Enzymatic Synthesis of Lanthionines.Mini-Reviews in Organic

Chemistry. 2(1):23-37.



Poey, M., Azpiroz, M., Lavina, M. (2006), Comparative analysis of chromosomeencoded microcins. Antimicrob Agents Chemother. 50: 14111418. Pons, M., Delalande, F., Duarte, M., Benoit, S., Lanneluc, I., Sabl, S., Van, D., Cottenceau, G. (2004).Genetic analysis and complete primary structure of microcin L. Antimicrob Agents Chemother. 48(2):505-513. Potrykus, J., and Grzegorz, W.(2001).Chloramphenicol-Sensitive Escherichia coli Strain Expressing the Chloramphenicol Acetyltransferase (CAT) Gene. Antimicrob. Agents

Chemother. 45(12): 3610-3612. Prema, P., Bharathy, S., Palavesam, A., Sivasubramanian, M., Immanuel, G. (2006). Detection, purification and efficacy of warnerin produced by Staphylococcus warneri. World Journal of Microbiology and Biotechnology .22 (8): 865-72. Rajaram, P., Manivasagan, B., Thilagavathi, A.,

Saravanakumar.(2010).Purification and Characterization of a Bacteriocin Produced by Lactobacillus lactis Isolated from Marine Environment.Advance Journal of Food Science and Technology. 2(2): 138-144. Ranjbar, R., Haghi-Ashtiani MT, Jonaidi Jafari N, Abedini M. (2009).The prevalence and antimicrobial susceptibility of bacterial uropathogens isolated from pediatric patients . Iranian. J .Publ. Health .38(2):134-138.



Reader, J., Ordoukhanian, G., Kim, V., de Crecy-Lagard, I., Hwang, S., Farrand, Schimmel, P. (2005). Major biocontrol of plant tumors targets tRNA Synthetase. Science. 309:1533-1542. Ricardo, E., de Cristobal, Jose O. Solbiati, Ana, M., Zenoff, Paula, A., Vincent, Raul, A., Salomon, Julia, Y., Konstantin, S., Ricardo, F.(2006). Microcin J25 Uptake: His5 of the MccJ25 Lariat Ring Is Involved in Interaction with the Inner Membrane MccJ25 Transporter Protein SbmA. Journal Of Bacteriology. 188(9): 33243328. Riccio, L., Pallecchi, L., Fontana, R., Rossolini,G.(2001). In70 of

plasmid pAX22, a blaVIM-1-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob Agents Chemother.45:1249-53. Rijavec, M,. Muller-Premru, M., Zakotnik, B., Zgur-Bertok, D. (2008). Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin. J. Med. Microbiol .57: 13291334. Riley, Margaret, A.(2011).Prokaryotic Antimicrobial Peptides, ISBN 978-1-4419-7691-8. Springer Science+Business Media, LLC. pp. 13-26 Ruiz, J., S. Bertran, G., Sauca, A., Julia`, X., Vila, E., Gomez, T., Jimenez de Anta1, Vilam, J. (2004).Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa .Clinical Microbiology and Infection. 11(1): 7173.



Sabahat, S., Perween, T. (2007). Antibacterial activities of emblica officinalis and coriandrum sativum against gram negative urinary pathogens. Pak. J. Pharm. Sci., 20:32-35. Sambrook, J., Rusell, W. (2001). Molecular cloning: a l laboratory manual. Cold spring Harbor, NY: Cold spring Harbor laboratory press.pp;563-572. Schito, C., Naber, H., Botto, J., Palou, T., Mazzei, L., Gualco, Marchese, A. (2009). The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents .34: 407-413. Severinov, K., Semenova, E., Kazakov, A., Kazakov, T., Gelfand, M.S.(2007).Lowmolecular-weight post-translationally

modified microcins. Mol. Microbiol. 65:1380-1394. Stanford, T., Shulman,. Herbert, C., Friedmann, and Ronald, H. Sims.(2007).Theodor Escherich: The First Pediatric

Infectious Diseases Physician?.Clin. Infect. Dis. 45 (8): 1025-1029. Stepper, J., Shastri, S., Loo, S., Preston, C., Novak, P., Man, P., Moore, H., Havlek, V., Patchett, A In L., New Norris, Post-

E.(2011).Cysteine Translational

s-Glycosylation, Found



Bacteriocins. FEBS letters. 585:645-650.



Suman, E., Jose, S., Varghese, Kotian, S. (2009). Study of biofilm production in Escherichia coli causing Urinary tract infection. Indian. J. Med. Microbiol., 25: 305-306. Supriya, S., Tankhiwale., V., Suresh., V., Jalgaonkar., D., Sarfraz, A., Umesh, H. (2004). Evaluation of extended spectrum beta lactamase in urinary isolates. Indian. J. Med. Res., 120: 553556. Sylvain, B., Filo, S., Claudio, S., Dominique, B. (2006).Bactericidal Activity of both Secreted and Nonsecreted Microcin E492 Requires the Mannose Permease. J. Bacteriol. 70497061. Tazebew, D., Getenet, B., (2012).Urinary Selabat, M., Wondewosen, Profile and T. 188(20):



Susceptibility Pattern Among Pregnant Women in North West Ethiopia.Ethiop. J. Health. Sci. 22(2): 121128. Teymur, K., Anastasia, M., Konstantin, S. (2007).Amino Acid Residues Required for Maturation, Cell Uptake, and Processing of Translation Inhibitor Microcin C. Journal Of Bacteriology. 189(5):21142118 . Thomas, H., Sandrine, D., Jean-Paul, P., Dominique, H,. Alain, D., Karine, V.(2003). Bacteriocin Detection from Whole Bacteria by Matrix-Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry. Applied And Environmental Microbiology. 69(2):10511058. Todar, K. (2008). Microbial world. Pathogenic Escherichia coli . University of Wisconsin-Madison. 375-390.



Todorov, S.D.(2009).Bacteriocins From Lactobacillus Plantarum Production, Genetic Organization And Mode Of Action. Brazilian Journal of Microbiology . 40:209-221. Triilzsch, K., Hoffman., K., Christain., N., Schub, Luts,

R.(2003).Highly resistant metabolically resistant dwarf mutant of Escherichia coli is the cause of chronic urinary tract infraction. J. Cli. Microbiol. 41: 5689-5694 Trine, N., Ingolf, F., Nes, Helge, H.(2003).Enterolysin A, a Cell Wall-Degrading Bacteriocin from Enterococcus faecalis LMG 2333.Applied and Environmental Microbiology. 69(5):2975-2984. Trujillo, M., Rodrguez, E., Lavia, M. (2001).ATP synthase is necessary for microcin H47 antibiotic action. Antimicrob Agents Chemother. 45(11):3128-3131. Van, Belkum, J., Martin-Visscher, A., Vederas, C. (2011). Structure and genetics of circular bacteriocins .Trends in Microbiology. 19(8): 411418. Van, den Elzen, PJ., Veltkamp, E., Nijkamp, HJ., Walters, HH. (1983). Molecular structure and function of the bacteriocin gene and bacteriocin protein of plasmid CloDF13. Nucleic Acids Res. 11 (8): 24652477. Vassiliadis, G., Destoumieux-Garzn, D., Lombard, C., Rebuffat, S., Peduzzi, J. (2010). Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47. Antimicrob Agents Chemother .54: 288-297.



Vera, E., Pingitore, E., Salvucci, F., Sesma, and M. E. NaderMacas.(2007).Different antimicrobial peptides strategies from for purification Acid of



(LAB).Communicating Current Research and Educational Topics and Trends in Applied Microbiology.557-568. Vinayak, A., Anastasiya, M., Konstantin S., and Satish K. N. (2011).Structural Basis for Microcin C7 Inactivation by the MccE Acetyltransferase.The Journal of Biological

Chemistry.286(24):21295-21303. Waters, VL., Crosa, JH. (1991). Colicin V virulence plasmids. Microbiol. Rev .55: 437450. Weigel, L., M., Anderson, G. J., Tenover, F. C., (2002) DNA gyrase and topoisomerase IV mutations associated with

fluoroquinolone resistance in Proteus mirabilis. Antimicrob Agents Chemother .46: 2582-2587. Winn , W. C., Allen , S. D. , Janda , W. M. , Koneman , E. W., Procop, G. W., Schreckenberger , P. C. and Woods , G. L.(2006). Koneman,s color atlas and textbook of diagnostic microbiology. 6th ED. Lippincott Williams and Wilkins, USA. PP:234-241. Yamazaki, K., Suzuki, Y., Kawai, N., Inoue, Montville, T.(2005) Purification and characterization of a novel class IIa bacteriocin, piscicocin CS526, from surimi-associated Carnobacterium piscicola CS526 .Applied and Environmental Microbiology. 71(1) : 554557.



Yann, H., Hans-Georg Sahlb(2002). Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie. 84(5-6):545-557. Zeus, S., Ayen, L., Erdem, Stephanie, S., Iruka, N., Okeke, Mark Lucas, Arunon, S., Alan, D., Phillips, James, B., Kaper, Jos, L., Puente, Jorge, A., Girn.(2009).The Escherichia coli Common Pilus and the Bundle-Forming Pilus Act in Concert during the Formation of Localized Adherence by

Enteropathogenic E. coli. J. Bacteriol. 191(11): 3451-3461. Zhanel, G., Hisanaga, N., Laing, R., DeCorby, A., Nichol, B., Weshnoweski, J., Johnson, A., Noreddin, E., Low, A., Karlowsky, Hoban, J. (2006) Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection

Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents .27: 468-475. Zihler, A., LeBlay, G., De Wouters, T., Lacroix, Braegger, C., Lehner,A., Tischler,P., Rattei,T., Hchler, H.,

Stephan,R.(2009).in vitro inhibition activity of different bacteriocin-producing Escherichia coli against Salmonella strains isolated from clinical cases. Letters in Applied Microbiology. 49 (1): 3138. Zschttig, A., Zimmermann, K., Blom, J., Goesmann, A., Phlmann, C., Florian, G.(2012) .Identification and Characterization of Microcin S, a New Antibacterial Peptide Produced by Probiotic Escherichia coli G3/10. Plos one .7(3): 1-7.



Larrea, M., E., P.(2011).Virulence Microcinas And Strains Of Escherichia coli In Uropathogen .ph.D.thesis .Physiology and Genetics Section of Bacterial.Faculty of Science. Montevideo. Uruguay. Keith, S., Kaye, M., John, J., Engemann, M., Henry, S., Fraimow, M., Elias, Abrutyn, M.(2004).Pathogens resistant to

antimicrobial agents: epidemiology, molecular mechanisms, and clinical management. Infect. Dis. Clin. N. Am. 18:467 511. Qi, C., V. Pilla, J., Yu, H., Reed, K. (2010). Changing prevalence of Escherichia coli with CTXM- type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008. Diagn. Microbiol. Infect. Dis. 67: 87-91.